echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Nat Neurosci: Zhang Guo/Cai Dongsheng/Li Juxue Team Finds That Inhibiting Tak1 Reverses Obesity-Related Cerebrovascular Disorder

    Nat Neurosci: Zhang Guo/Cai Dongsheng/Li Juxue Team Finds That Inhibiting Tak1 Reverses Obesity-Related Cerebrovascular Disorder

    • Last Update: 2020-05-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Long-term obesity is associated with cerebrovascular dysfunction, however, our basic mechanisms are still unclearin a recent study using a long-term obese mouse model with basal artery (BA) abnormalities, researchers found that the small glial conversion growth factor beta-activated kinase 1 (Tak1) was overactive in the brain stemdrug suppression of Tak1 in brain stem or selective removal of Tak1 in small glial cells improved BA vascular dysfunctionConversely, in normally fed mice, specific activation of Tak1 in small glial cells in the brain stem was sufficient to cause BA dysfunctionMechanism, Tak1 activation leads to an increase in the production of leukocyte interleukin-18 (IL-18), while in the context of long-term obesity, blocking IL-18 receptors in the brain helps protect the cerebrovascular dysfunctionThe selective removal of Tak1 by small glial cells also protects individuals from chronically obese brain ischemic strokesin summary, these findings provide evidence that Tak1, a small glial cell in the brain, especially in the brain stem, is involved in the pathogenesis of obesity-related cerebrovascular dysfunction
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.